The pathophysiological role of fibrinolysis inhibitors.
D000933:Antifibrinolytic Agents / Q000502:physiology*; D005337:Fibrin / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism; D005342:Fibrinolysis; D006801:Humans; D010958:Plasminogen / Q000172:deficiency / Q000378:metabolism; D010960:Plasminogen Activators / Q000378:metabolism; D013924:Thrombophlebitis / Q000378:metabolism; D000979:alpha-2-Antiplasmin / Q000378:metabolism; D000511:alpha-Macroglobulins / Q000378:metabolism
D000933:Antifibrinolytic Agents; D000979:alpha-2-Antiplasmin; D000511:alpha-Macroglobulins; D005337:Fibrin; D010958:Plasminogen; D010960:Plasminogen Activators; D005341:Fibrinolysin